Venus Remedies has presented positive results of the investigational NCE VRP1620 after completion of meticulously planned, managed, executed and analyzed two pivotal Phase-1 & Phase-11 clinical trials. The company is planning to launch this NCE by last quarter of 2013 in India
Indoco Remedies is currently trading at Rs 63.95, up by 0.60 points or 0.95% from its previous closing of Rs 63.35 on the BSE.
The scrip opened at Rs 64.65 and has touched a high and low of Rs 66.45 and Rs 63.95 respectively. So far 21610 shares were traded on the counter.
MCX tips| Commodity tips
Description
This is quite informative, we all should be careful.
The Forces Involved
The amount of force you place on your back in lifting may surprise you! Think of your back as a lever. With the fulcrum in the center, it only takes ten pounds of pressure to lift a ten pound object.
The...
Sore throats are the most common reason that patients visit a doctor. The tonsils and throat are very open to infection due to the contaminated air that flows through the area. The contaminated air contains pollutants, bacteria and viruses that attack throat tissue.
What is a sore throat?
Sore...